Mounjaro contains the active ingredient tirzepatide, a medication that helps regulate appetite by promoting feelings of fullness and reducing hunger. It is used for weight loss and weight maintenance in adults and for the treatment of type 2 diabetes when combined with other medications or as a standalone option.
Mounjaro is administered as a weekly subcutaneous injection via a KwikPen. It is recommended for:
- Adults with a BMI of 30 kg/m² or higher (obesity).
- Adults with a BMI of 27–29.9 kg/m² (overweight) with weight-related conditions such as type 2 diabetes, high blood pressure, or sleep apnoea.

Reviews
Clear filtersThere are no reviews yet.